Patient-Reported Utility on Pembrolizumab (Pembro) and Ipilimumab (Ipi) among Ipi Naïve Patients with Advanced Melanoma
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1467
https://www.valueinhealthjournal.com/article/S1098-3015(16)01535-7/fulltext
Section Title :
Cancer - Patient-Reported Outcomes & Patient Preference Studies
Section Order :
352
First Page :
A157
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01535-7&doi=10.1016/j.jval.2016.03.1467